Canadian Rx-to-OTC switches
This article was originally published in The Tan Sheet
Executive Summary
Special Committee of Council approves three switches: nicotine transdermal patches (22 mg/day and less), effective June 1; nizatidine (75 mg), effective immediately; and sodium cromoglycate (2% nasal solution), effective June 15. Eli Lilly Canada has rights to a 100 mg and 300 mg Rx nizatidine. Health Canada does not release the names of companies that apply for switches. The deregulatory amendments will be published in the Canada Gazette Part II May 27...